Basic Information
NeurOp, Inc. is an Atlanta-based clinical-stage biopharmaceutical company developing novel drugs for central nervous system disorders, including stroke, severe pain, subarachnoid hemorrhage, and treatment-resistant depression. Its technology targets the GluN2B subunit of neuronal NMDA receptors and their potential therapeutic benefits.
NeurOp, Inc.
Atlanta,Georgia,United States of America
less than 15 people
January 01, 2002
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios